Use the filters below to search the library by product or by resource type
FiltersClear Filters
Results Found:
Onco Tracker Collaboration
sBCMA test may both monitor and predict outcomes in multiple myeloma and other blood cancers ONCOtracker.
Thermo Fisher Scientific to Acquire The Binding Site Group
Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma.
Mark Stevenson
The Binding Site, a global leader in specialist protein diagnostics, has appointed Mark Stevenson as new non-executive Chairperson.
iStopmm Trial Methods Paper Publication
Binding site is pleased to announce that the methods paper for the landmark iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) study has now been published.